ALKS
Alkermes Plc
Price:  
29.69 
USD
Volume:  
2,089,082.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alkermes EV/EBITDA

50.6%
Upside

As of 2024-03-01, the EV/EBITDA ratio of Alkermes Plc (ALKS) is 11.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Alkermes's latest enterprise value is 4,432.02 mil USD. Alkermes's TTM EBITDA according to its financial statements is 371.82 mil USD. Dividing these 2 quantities gives us the above Alkermes EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.3x - 13.7x 13.0x
Forward P/E multiples 17.9x - 19.0x 18.4x
Fair Price 30.63 - 59.01 44.72
Upside 3.2% - 98.8% 50.6%
29.69 USD
Stock Price
44.72 USD
Fair Price

Alkermes EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-01 12.17
2024-02-29 11.92
2024-02-28 11.97
2024-02-27 11.92
2024-02-26 12.08
2024-02-23 11.87
2024-02-22 11.57
2024-02-21 11.69
2024-02-20 12.23
2024-02-16 13.04
2024-02-15 13.21
2024-02-14 11.16
2024-02-13 10.82
2024-02-12 11.39
2024-02-09 10.86
2024-02-08 10.61
2024-02-07 10.58
2024-02-06 10.73
2024-02-05 10.44
2024-02-02 10.60
2024-02-01 10.69
2024-01-31 10.73
2024-01-30 10.90
2024-01-29 11.30
2024-01-26 11.04
2024-01-25 11.17
2024-01-24 11.22
2024-01-23 11.40
2024-01-22 11.37
2024-01-19 11.12
2024-01-18 11.05
2024-01-17 11.02
2024-01-16 11.05
2024-01-12 11.25
2024-01-11 11.13
2024-01-10 11.23
2024-01-09 11.60
2024-01-08 11.88
2024-01-05 11.41
2024-01-04 11.44
2024-01-03 11.46
2024-01-02 11.44
2023-12-29 11.04
2023-12-28 11.11
2023-12-27 11.19
2023-12-26 11.10
2023-12-22 11.13
2023-12-21 10.96
2023-12-20 10.79
2023-12-19 11.04